ZLAB
Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib in China
Thursday, February 17, 2022 1 min read
Key Takeaway: Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib in China
Full Press Release Details
Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib in China.